IT201700040937A1 - ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES - Google Patents

ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES

Info

Publication number
IT201700040937A1
IT201700040937A1 IT102017000040937A IT201700040937A IT201700040937A1 IT 201700040937 A1 IT201700040937 A1 IT 201700040937A1 IT 102017000040937 A IT102017000040937 A IT 102017000040937A IT 201700040937 A IT201700040937 A IT 201700040937A IT 201700040937 A1 IT201700040937 A1 IT 201700040937A1
Authority
IT
Italy
Prior art keywords
antocianidines
inflammatory
prevention
treatment
metabolic diseases
Prior art date
Application number
IT102017000040937A
Other languages
Italian (it)
Inventor
Stefano Fiorucci
Gabriele Costantino
Giannamaria Annunziato
Original Assignee
Giannamaria Annunziato
Gabriele Costantino
Stefano Fiorucci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giannamaria Annunziato, Gabriele Costantino, Stefano Fiorucci filed Critical Giannamaria Annunziato
Priority to IT102017000040937A priority Critical patent/IT201700040937A1/en
Publication of IT201700040937A1 publication Critical patent/IT201700040937A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
IT102017000040937A 2017-04-12 2017-04-12 ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES IT201700040937A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000040937A IT201700040937A1 (en) 2017-04-12 2017-04-12 ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000040937A IT201700040937A1 (en) 2017-04-12 2017-04-12 ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES

Publications (1)

Publication Number Publication Date
IT201700040937A1 true IT201700040937A1 (en) 2018-10-12

Family

ID=59683965

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000040937A IT201700040937A1 (en) 2017-04-12 2017-04-12 ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES

Country Status (1)

Country Link
IT (1) IT201700040937A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168221A1 (en) * 2008-12-31 2010-07-01 Industrial Technology Research Institute Pharmaceutical composition for treating hepatitis b virus and health food product having hepatitis b virus inhibiting effects
WO2011048479A2 (en) * 2009-10-21 2011-04-28 Maqui New Life S.A. Compositions that include anthocyanidins and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168221A1 (en) * 2008-12-31 2010-07-01 Industrial Technology Research Institute Pharmaceutical composition for treating hepatitis b virus and health food product having hepatitis b virus inhibiting effects
WO2011048479A2 (en) * 2009-10-21 2011-04-28 Maqui New Life S.A. Compositions that include anthocyanidins and methods of use

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
COOKE D ET AL: "Anthocyans from fruits and vegetables - Does bright colour signal cancer chemopreventive activity?", EUROPEAN JOURNAL OF CANCER, ELSEVIER, AMSTERDAM, NL, vol. 41, no. 13, 9 August 2005 (2005-08-09), pages 1931 - 1940, XP027785512, ISSN: 0959-8049, [retrieved on 20050901] *
GRAMSHAW ET AL.: "813. The synthesis of Flavan-2:3-diols (dihydro-alpha:2-dihydroxy-chalcones)", JOURNAL OF THE CHEMICAL SOCIETY, 1958, pages 4040 - 4049, XP002774031 *
KAMENICKOVA ALZBETA ET AL: "Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell l", TOXICOLOGY LETTERS, vol. 221, no. 1, 2 June 2013 (2013-06-02), pages 1 - 8, XP028595319, ISSN: 0378-4274, DOI: 10.1016/J.TOXLET.2013.05.007 *
KING ET AL.: "The Chemistry of Extractives from Hardwood. Part XXV. (-)-epiAfzelechin, a New Member of the Catechin Series.", JOURNAL OF THE CHEMICAL SOCIETY, 1955, pages 2948 - 2956, XP002774032 *
LIOBIKAS JULIUS ET AL: "Anthocyanins in cardioprotection: A path through mitochondria", PHARMACOLOGICAL RESEARCH, vol. 113, 30 March 2016 (2016-03-30), pages 808 - 815, XP029811333, ISSN: 1043-6618, DOI: 10.1016/J.PHRS.2016.03.036 *
SONIA DE PASCUAL-TERESA ET AL: "Flavanols and Anthocyanins in Cardiovascular Health: A Review of Current Evidence", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 11, no. 4, 13 April 2010 (2010-04-13), pages 1679 - 1703, XP055392878, DOI: 10.3390/ijms11041679 *
WANG L S ET AL: "Anthocyanins and their role in cancer prevention", CANCER LETTERS, NEW YORK, NY, US, vol. 269, no. 2, 8 October 2008 (2008-10-08), pages 281 - 290, XP025496527, ISSN: 0304-3835, [retrieved on 20080620], DOI: 10.1016/J.CANLET.2008.05.020 *

Similar Documents

Publication Publication Date Title
MA45192A (en) ASSOCIATION TREATMENT
IL273693A (en) Treatment of inflammatory disorders
DK3347030T3 (en) USE OF PASTEURIZED AKKERMANSIA FOR THE TREATMENT OF METABLE DISEASES
DK3889145T3 (en) 8-cyano-5-piperidino-quinolines as TLR7/8 antagonists and uses thereof for the treatment of immune diseases
IL262608A (en) Combination treatment of ocular inflammatory disorders and diseases
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
IL255109A0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ITUA20161846A1 (en) PROCEDURE AND ARCHITECTURE OF REMOTE ADJUSTMENT OF AN AUDIOPROSTHESIS
ES2966369T3 (en) Compounds and methods for the treatment of parasitic diseases
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP3408413A4 (en) Prediction of therapeutic response in inflammatory conditions
MA43106A (en) TREATMENT OF OLIGO-OVULATION ASSOCIATED WITH HEPATIC STEATOSIS
FR3022139B1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA
DK3229827T3 (en) MODIFIED PEPTIDES AND ITS APPLICATION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES
IT201700121764A1 (en) Composition for the treatment and / or prevention of neurodegenerative diseases.
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB201515244D0 (en) Treatment of inflammatory disease or condition
IT201700111261A1 (en) Composition for the treatment of metabolic and mechanical neuropathies
DK3515409T3 (en) COMPLEX AND COMPOSITIONS FOR THE TREATMENT OF OTHAL MOLOGICAL AND DERMATOLOGICAL DISEASES
IT201700060506A1 (en) Composition for the prevention and / or treatment of diseases associated with inflammation and / or hyperalgesia
SG10201913129QA (en) Treatment and diagnosis of inflammatory disorders
ITUB20160121A1 (en) GABAPENTIN OFTALMIC FOR THE TREATMENT OF CORNEAL ULCERS
IT201700040937A1 (en) ANTOCIANIDINES FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY AND METABOLIC DISEASES
KR20180085033A (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF SKIN DISEASES
DK3383381T3 (en) Compound for use in the prevention and treatment of neurodegenerative diseases